Evidence map›Paper›PMID 37766133›Full record

ArticleVaccines2023

Population-Level Immunity for Transient Suppression of COVID-19 Waves in Japan from April 2021 to September 2022.

Sachiko Kodera, Haruto Ueta, Tatsuo Unemi, Taisuke Nakata, Akimasa Hirata

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sachiko KoderaCenter of Biomedical Physics and Information Technology, Nagoya Institute of Technology, Nagoya 466-8555, Japan.ORCID 0000-0001-6595-0742
Haruto UetaDepartment of Electrical and Mechanical Engineering, Nagoya Institute of Technology, Nagoya 466-8555, Japan.
Tatsuo UnemiGlycan and Life Systems Integration Center, Soka University, Tokyo 192-8577, Japan.
Taisuke NakataGraduate School of Economics, University of Tokyo, Tokyo 113-0033, Japan.
Akimasa HirataCenter of Biomedical Physics and Information Technology, Nagoya Institute of Technology, Nagoya 466-8555, Japan.ORCID 0000-0001-8336-1140
Nagoya Institute of Technology · JPSoka University · JPThe University of Tokyo · JP

Funding

Cabinet Office COVID-19 AI Simulation Project
6 · The paper itself

Abstract

Multiple COVID-19 waves have been observed worldwide, with varying numbers of positive cases. Population-level immunity can partly explain a transient suppression of epidemic waves, including immunity acquired after vaccination strategies. In this study, we aimed to estimate population-level immunity in 47 Japanese prefectures during the three waves from April 2021 to September 2022. For each wave, characterized by the predominant variants, namely, Delta, Omicron, and BA.5, the estimated rates of population-level immunity in the 10-64-years age group, wherein the most positive cases were observed, were 20%, 35%, and 45%, respectively. The number of infected cases in the BA.5 wave was inversely associated with the vaccination rates for the second and third injections. We employed machine learning to replicate positive cases in three Japanese prefectures to validate the reliability of our model for population-level immunity. Using interpolation based on machine learning, we estimated the impact of behavioral factors and vaccination on the fifth wave of new positive cases that occurred during the Tokyo 2020 Olympic Games. Our computational results highlighted the critical role of population-level immunity, such as vaccination, in infection suppression. These findings underscore the importance of estimating and monitoring population-level immunity to predict the number of infected cases in future waves. Such estimations that combine numerical derivation and machine learning are of utmost significance for effective management of medical resources, including the vaccination strategy.

Indexed as

asymptomatic infectionsherd immunitymachine learningOlympic Gamestransient suppressionvaccination effectiveness

Identifiers

PMID37766133
PMCPMC10537865
OpenAlexW4386465565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.